eli lilly retatrutide clinical trials Phase 3 obesity trial results 2026 Eli Lilly obesity drug retatrutide

Open questions The authors cautioned that the trial was a small pilot study and not randomized, adding that all participants had obesity

By helping reduce appetite and improve metabolic regulation, Ozempic has become a popular choice for patients seeking effective weight loss solutions

The most serious side effects include pancreatitis (severe abdominal pain), kidney problems, gallbladder disease, and vision changes

Systolic pressure (the top number) measures force during heart contraction, while diastolic pressure (the bottom number) reflects force between heartbeats

4,6,7 Large observational analyses have reported lower risks for several neuropsychiatric outcomes, including substance use and psychotic disorders